Financial statements Bioimpact
Balance sheet of Bioimpact
Company age:
Age:
10 y. 8 m.
Share capital:
Share capital:
5 000 PLN
Company suspended its operations from 2024-06-13
Balance sheet data of BIOIMPACT
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 56 624,19 | 45 788,95 | 8 302,69 | 17 093,80 | 54 987,87 | 20 252,76 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 2 719,51 | 0,00 |
| B. Current assets | 56 624,19 | 45 788,95 | 8 302,69 | 17 093,80 | 52 268,36 | 20 252,76 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | - | - |
| Total liabilities | 56 624,19 | 45 788,95 | 8 302,69 | 17 093,80 | 54 987,87 | 20 252,76 |
| A. Equity | -28 990,94 | 12 551,02 | -83 055,85 | -5 080,04 | -114 027,44 | -185 962,29 |
| B. Liabilities and provisions for liabilities | 85 615,13 | 33 237,93 | 91 358,54 | 22 173,84 | 169 015,31 | 206 215,05 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 85 615,13 | 33 237,93 | 91 358,54 | 22 173,84 | 169 015,31 | 206 215,05 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.